NCT06635824 · Interventional trial
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
Overall registry status Active not recruiting
Phase 3
Conditions PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
Delaware Valley sites
- University of Pennsylvania Health System · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory